Nurturing a team of excellent researchers includes promoting rising stars; this year included three PHRI Investigators becoming Scientists, and we couldn’t be more proud of them!
Flavia Kessler Borges works with PHRI Senior Scientist PJ Devereaux and others in the perioperative research team. She is an Assistant Professor, McMaster’s Department of Medicine (perioperative care, general internal medicine), and her research is focused on perioperative cardiac biomarkers, and perioperative strategies to improve clinical outcomes in patients undergoing noncardiac surgery.
She undertook her Masters in Health Sciences and her PhD in Cardiovascular Sciences in Brazil, and a research and clinical perioperative vascular fellowship under the direction of Devereaux at McMaster. Borges, in turn, is now supervising PHRI Research Fellow Ana Claudia Tonelli, a fellow Brazilian, on the HIP ATTACK-2 trial and other research. Borges was an investigator and coauthor on the POISE-3 trial, presented at ACC 2022 and published in NEJM.
Noel Chan works with PHRI Senior Scientist John Eikelboom and others in the thrombosis research group at PHRI, and an Assistant Professor in the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, specializing in anticoagulant therapy and thrombosis medicine.
Chan’s current research work includes ACT COAG (substudy of ACT COVID-19), which is measuring the effect of study treatments on coagulation biomarkers to identify the most promising therapies and unravel mechanisms of thrombotic complications. He is also investigating if anti-inflammatory therapy with colchicine will reduce cardiovascular and limb events in patients with peripheral artery disease, in the LEADER PAD trial.
Jorge Wong works with PHRI Senior Scientists Jeff Healey and Stuart Connolly in the arrhythmia and heart failure program; his interests focus primarily on the intersection between atrial fibrillation and heart failure, atrial fibrillation epidemiology and catheter ablation for atrial fibrillation. He is studying bariatric surgery for HF patients in the BRAVE trial, and looking at the prevalence of subclinical atrial fibrillation in high-risk HF patients (PROTECT-HF).
Wong completed his clinical electrophysiology fellowship at the University of Calgary and at the Brigham and Women’s Hospital in Boston. He has a Master of Public Health degree from the Harvard School of Public Health, and is currently pursuing his PhD in Health Research Methods at McMaster.
We’re also proud to announce the following promotions:
- Michael Wang to PHRI Investigator from Research Fellow
- Emmanuelle Duceppe to Associate Scientist from PHRI Associate Investigator
- Russell De Souza to Associate Scientist from PHRI Associate Investigator
- Gita Wahi to PHRI Associate Investigator from Research Fellow